Tesamorelin is a synthetic peptide designed to stimulate the release of endogenous GH. In research settings, it is primarily investigated for its role in reducing visceral adipose tissue and regulating lipid metabolism. Tesamorelin has shown particular promise in metabolic and endocrine studies focused on insulin-like growth factor-1 (IGF-1) pathways. 

For non-theraputic research use.

This product is intended solely for qualified laboratory professionals and academic research.